INS and COVID-19: Apart from metformin and insulin analogues, the most common concomitant medications were paracetamol (6 [2.4%] patients), COVID-19 vaccines (4 [1.6%] patients), and nonsteroidal anti-inflammatory medicines (4 [1.6%] patients).